Pacific Edge eyes final US milestone within year

Pacific Edge eyes final US milestone within year
Gavin Evans
By Gavin Evans Aug 1 (BusinessDesk) - Pacific Edge says it may achieve the key third element for reimbursement by private and public US health insurers for its Cxbladder cancer diagnostic tests within a year. The firm has already been granted a national price for its tests and two of its products have been granted national product codes for the US. Studies of Cxbladder published in European Urology and the New Zealand Medical Journal this year, and the products’ inclusion this month in the US National Comprehensive Cancer Network Guide...

More Services

Aussie fund manager Shaws buys Devon Funds
Finance

Aussie fund manager Shaws buys Devon Funds

The deal is the latest tie-up between Australian and NZ funds managers.

Staff reporters 24 Jun 2025
Buy NZ Made's new service trademark sets high bar
Services

Buy NZ Made's new service trademark sets high bar

One certified business says it sets it apart from multinational competitors.

John Anthony 23 Jun 2025
Reel pain: Strikes hit NZ cinemas, profits dive
Services

Reel pain: Strikes hit NZ cinemas, profits dive

Cinema chains in NZ face box office suspense.

Victoria Young 28 May 2025
PEP seeking payday from UP Education
Finance

PEP seeking payday from UP Education

UP Education is a NZ success story in Australia.

Pattrick Smellie 23 Apr 2025